- Price
Supplier Type
- Manufacturer
- Trader
- contract manufacturer
- custom synthesis
- Reagent
Supplier Region
- Mumbai(24)
- Telangana(40)
- AndhraPradesh(6)
- Hyderabad(21)
- Gujarat(81)
- Maharashtra(98)
- Madhya Pradesh(6)
- Karnataka(13)
- Uttar Pradesh(9)
- New Delhi(12)
- Tamil Nadu(7)
- Punjab(1)
- Bangalore(2)
- Kolkata(1)
- Haryana(2)
- Rajasthan(3)
- Ahmedabad(2)
- West Bengal(3)
- Himachal Pradesh(1)
- Kerela(1)
- Andhra Pradesh(2)
- Vadodara(3)
- Delhi(1)
- Beijing(2)
Purity
- United States Pharmacopeia (USP) Reference Standard
- Type I-S, 65-85% protein (≥75% of protein is clottable)
- PVP K-30)
- purum, 45% FeCl3 basis
- purum p.a., anhydrous, ≥98.0% (KT)
- powder, EMPROVE? ESSENTIAL, Ph. Eur., BP, JP, USP, E 331
- powder
- Pharmaceutical Secondary Standard
- Multi-Compendial
- Mr ~100,000
- meets USP testing specifications
- HCl 95%
- Grade IV, Histone, free(Millon test)
- Grade III, histone, free(Millon test)
- for synthesis
- for analysis EMSURE? ACS,ISO,Reag. Ph Eur
- for analysis EMPARTA? ACS
- European Pharmacopoeia (EP) Reference Standard
- Divergan RS
- Dextran 70 United States Pharmacopeia (USP) Reference Standard
- Dextran 40 United States Pharmacopeia (USP) Reference Standard
- Dextran 4 United States Pharmacopeia (USP) Reference Standard
- Dextran 250 United States Pharmacopeia (USP) Reference Standard
- Dextran 10 United States Pharmacopeia (USP) Reference Standard
- Dextran 1 United States Pharmacopeia (USP) Reference Standard
- crystalline, EMPROVE? ESSENTIAL, Ph. Eur., BP, JP, USP, E 331
- CRS, European Pharmacopoeia (EP) Reference Standard
- Certified Reference Material
- avg mol. wt. 40,000
- AR
- anhydrous
- AnhydroBeads?, ?10?mesh, 99.995% trace metals basis
- AnhydroBeads?, ?10?mesh, 99.9% trace metals basis
- analytical standard, for GPC, 80,000
- analytical standard, for GPC, 670,000
- analytical standard, for GPC, 50,000
- analytical standard, for GPC, 5,000
- analytical standard, for GPC, 410,000
- analytical standard, for GPC, 270,000
- analytical standard, for GPC, 25,000
- analytical standard, for GPC, 150,000
- analytical standard, for GPC, 12,000
- analytical standard, for GPC, 1,000
- AldrichCPR
- ACS reagent
- A cell-permeable quinone reductase inhibitor with anticoagulant properties.
- 99.9%
- 99.7%
- >99.0%(HPLC)
- 99%+
- 99%
- 98.5-101%
- ≥98.5% (NT)
- >98.0%(T)(HPLC)
- >98.0%(T)
- >98.0%(HPLC)(N)
- >98.0%(HPLC)
- >98.0%(GC)
- ≥98.0% (dried material)
- ≥98.0% (calc. based on dry substance, AT)
- 98%+
- ≥98% (HPLC), powder
- ≥98% (HPLC)
- >98% (HPLC)
- 98%
- ≥98%
- >98%
- >97.0%(T)(HPLC)
- 97%
- 95-99%
- 95-99 %
- 95-105 mg/mL (Iron content), solution
- >95.0%(GC)(T)
- >95.0%(GC)
- ≥95% (HPLC)
- 95%
- >85.0%(HPLC)
- 60-80% protein (≥60% of protein is clottable)
- 50-70% protein (≥80% of protein is clottable)
- 35-65% protein (≥90% of protein is clottable).
- 150 IU/mg
- 100 Kilograms
- ~100 mg/mL solution
- (1,10-phenanthroline iron(II) sulfate) 1/40 mol/l redox indicator
- &ge
Package
- 0Customized pack size availaible
- 0As per requirement
- 0the rest upon order
- 15mg
- 50mg
- 120mg
- 0.18
- 70mg
- SAMPLE-K
- 1mg
- 5mg
- 10mg
- 100mg
- 150mg
- Kilogram
- 1932190521
- 25mg
- 200mg
- 250MG
- Bottle
- Kg
- Kilograms
- mg
- Gram
- Litre
- 300mg
- 0.3mL
- 350mg
- 400mg
- 500MG
- 800mg
- 1gm
- 1G
- 1mL
- 1200mg
- 2g
- 5gm
- 5G
- 5ML
- 10g
- 10gm
- 10G-F
- 25G
- 25mL
- 25gm
- 50gm
- 1Vial
- 50G-F
- 50mL
- 50g
- 100mL
- 100G
- 100gm
- 250G-F
- 250g
- 250gm
- 1set
- 500mL
- 500gm
- 1kg
- 2kg
- 25125kg and 1 MT
- 500G
- 1L
- 2.5kg
- 111kg or above 1kg needs enquiry
- 2.5L
- 3kg
- 1001100mg and 1 g
- 5kg
- 5lt
- 255025 to 50 kg
- 10kg
- 12kg
- 25kg
- 50kg
- 60kg
- 1000kg
- 1MT
- 10 kg
- 18%
- 151-5 gm
- 1vail
- 1amp
- 1 kg
- 5Gms
- 5 kg
- 10mt
- 10Gms
- 20K.Units
- 25Gms
- 25kgs
- 50kgs
- 100Gms
- 100K.Units
- 250Gms
- 500Gms
- 20000Units
- 100000Units
Sodium Starch Glycolate 9063-38-1
Clopidogrel Bisulphate Form II 135046-48-9
4-(4-METHYLPIPERAZINOMETHYL)BENZOIC ACIDDIHYDROCHLORIDE 106261-49-8
4-(4-Methylpiperazin-1-yl)methylbenzoic acid dihydrochloride 106261-49-8
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride ( Imatinib Intermediate) 106261-49-8